Tanja Badovinac-crnjevic

2 Patents

• US122525492025

  Pertuzumab Plus Trastuzumab Fixed Dose Combination

  Hoffmann-la Roche Inc.

  0 cites
• US116541052023

  Subcutaneous HER2 Antibody Formulations

  Hoffmann-la Roche

  0 cites